Молекулярно-генетические методы в изучении эпидемиологии инфекций, возбудители которых передаются парентеральным путем
Диссертация
Существовала возможность распространения в России и других инфекций, передающиеся парентеральным путем и часто встречающихся в группе потребителей наркотиков в других странах. К их числу относится инфекция, вызываемая вирусом Т-клеточного лейкоза человека типа II (HTLV-II), которая распространена среди ВИЧ-инфицированных наркоманов в Европе и Северной Америке. Поскольку, как ранее было показано… Читать ещё >
Список литературы
- Асеев М.В., Шауи А., Дин М., Баранов B.C. Популяционные особенности частот мутации гена хемокинового рецептора CKR-5, определяющего чувствительность к вирусу СПИДа. Генетика, 1997,33: 1724−1726.
- Бобков А.Ф., Покровский В. В., Селимова Л. М., Ладная Н. Н., Казеннова Е. В., Карасева Н. Г., Кравченко А.В, Чейнсонг-Попов Р., Вебер Дж. Генотипирование и филогенетический анализ изолятов ВИЧ-1, циркулирующих в России. Вопросы вирусологии, 1997, 42:13−16.
- Галеева А.Р., Хусиутдинова Е. К., Сломинский П. А., Лимборская С. А. Распространенность делении 32 пн в гене рецептора хемокинов CCR5 в популяциях Волго-Уральского региона. Генетика, 1998, 34: 1160−1162.
- Гланц С. Медико-биологическая статистика. Москва, «Практика», 1999.
- Кожевникова Г. М., Рослый И. М., Чуйкова К. И., Бобкова М. Р. Клинико-лабораторная характеристика острого вирусного гепатита С у потребителей парентеральных наркотических веществ. Терапевтический архив, 1999, 71 (11): 1014.
- Канестри В.Г., Кравченко А. В. Особенности вирусного гепатита С у больных ВИЧ-инфекцией. Мед. помощь, 2001, 2: 21−24.
- Кожевникова Г. М., Серова В. В., Бобкова М. Р., Деткова Н. В. Вирусные гепатиты В и С у потребителей психотропных препаратов, вводимых внутривенно. Журнал микробиологии, эпидемиологии и иммунологии, 2000, 4: 49−53.
- Кулаичев А.П. Методы и средства анализа данных в среде Windows STADIA. М., НПО «Информатика и компьютеры», 1999.
- Ладная Н.Н., Покровский В. В., Бобков А. Ф., Селимова Л. М., Савченко И. Г., Казеннова Е. В., Карасева Н. Г., Кравченко А. В., Бочкова М. С. Распространение субтипов ВИЧ-1 в России. Эпидемиология и инфекционные болезни, 1998,3: 19−23.
- Лейникки П., Литсола К., Лаукканен Т., Салминен М., Смольская Т., Коровина Г., Власов Н. Идентификация генетических субтипов ВИЧ-1, циркулирующих на территории России. Журнал микробиологии, эпидемиологии и иммунологии, 1996, 6: 25−28.
- Львов Д.К., Дерябин П. Г. географическое распространение вируса гепатита С и его генотипов. Вопросы вирусологии, 1997а, 42: 196−199.
- Львов Д.К., Миширо С., Селиванов Н. А., Самохвалов Е. И., Шахгильдян И. В. и др. Распространение генотипов гепатита С, циркулирующих на территориях СевероЗападной и Центральной частей России. Вопросы вирусологии, 1995,40 (6): 251−253.
- Львов Д.К., Самохвалов Е. И., Миширо С. и др. Закономерности распространения вируса гепатита С и его генотипов в России и странах СНГ. Вопросы вирусологии, 1997b, 42 (4): 157−161.
- Маниатис Т., Фрич Э., Сэмбрук Дж. Методы генетической инженерии. Молекулярное клонирование. Москва, Мир, 1984.
- Падюков Л.Н., Бобкова М. Р. Способ получения иммуносорбента для диагностики вирусного гепатита С. Патент РФ N 2 095 815, бюллетень N 31, 10 ноября 1997 г., G01N 33/543.
- Петракова Н.В., Калинина Т. И., Худяков Ю. Е., Газина Е. В., Смирнов В. Д. Получение и очистка полипептида, содержащего антигенные детерминанты core белка вируса гепатита С. Вопросы вирусологии, 1997, 42 (5): 208−212. 124−126.
- Покровский В.В. Эпидемиология и профилактика ВИЧ-инфекции и СПИД. Москва, «Медицина», 1996а.
- Покровский В.В., Ермак Т. Н., Беляева В. В., Юрин О. Г. ВИЧ-инфекция: клиника, диагностика и лечение. Москва, «Гэотар Медицина», 2000.
- Покровский В.В., Ладная Н. Н., Соколова Е. В., Буравцова Е. В. ВИЧ-инфекция. ВИЧ-инфекция. Информационный бюллетень N 21. Федеральный научно-методический Центр МЗ РФ по профилактике и борьбе со СПИДом, Москва, 2001.
- Покровский В.В., Ладная Н. Н., Савченко И. Г., Голиусов А. Т., Наркевич М. И., Бочкова М. С., Буравцова Е. В., Кулагин В. В., Колесник А. Н., Момот О. Ф., Саухат С. Р. Эпидемия ВИЧ-инфекции в России. Эпидемиология и инфекционные болезни, 1998а, 5:4−11.
- Покровский В.В., Савченко И. Г., Ладная Н. Н., Буравцова Е. В., Бочкова М. С. ВИЧ-инфекция. Информационный бюллетень N 10. Российский научно-методический центр по профилактике и борьбе со СПИДом, Москва, 1997.
- Покровский В.В., Савченко И. Г., Ладная Н. Н., Буравцова Е. В., Бочкова М. С., Арзамасцев В. П., Корнеева М. И. ВИЧ-инфекция. Информационный бюллетень N 14. Российский научно-методический центр по профилактике и борьбе со СПИДом, Москва, 1998b.
- Семилетов Ю.А., Фирсова Т. В., Кузин С. Н., Шибнев В. А., Вязов С. О. Антигенная активность синтетических пептидов фрагметов белков вируса гепатита С. Доклады Академии наук, 1993, 333 (3): 395−397.
- Соринсон С.Н. Вирусные гепатиты (2-е издание). С.-Петербург, «Теза», 1998.
- Суворова З.К., Буравцова Е. В., Деулина М. О., Покровский В. В. Серологическая диагностика инфекций, вызываемых ВИЧ, иммуноферментными методами. Медицинская помощь, 1993, 5: 22−24.
- Шипулин Г. А., Саркисян К. А., Богословская Е. В., Шипулина О. В., Воробьева М. С. Место полимеразной цепной реакции в диагностике ВИЧ-инфекции. Эпидемиология и инфекционные болезни, 1998, 5: 59−63.
- Aarons Е, Fernandez М, Rees A, McClure М, Weber J. CC-chemokine receptor 5 genotypes and in vitro susceptibility to HIV-l of a cohort of British HIV-exposed uninfected homosexual men. AIDS, 1997, 11 (5): 688−689.
- Aboulafia DM, Mitsuyasu RT, Slamon DJ: Human T-cell leukemia virus infection in non-intravenous drug using HIV seropositive men in Los Angeles. AIDS Res Hum Retroviruses, 1991, 7: 333−336.
- Afdhal NH. Immunology and pathogenesis of hepatitis С virus. American Association for the study of liver diseases. 51st Annual meeting and postgraduate course. Day 1 October 27,2000.
- Alizon M, Wain-Hobson S, Montagnier L, Sonigo P. Genetic variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients. Cell, 1986,46 (1): 63−74.
- Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, Berger EA. CC CKR5: a RANTES, MIP-1 alpha, MlP-lbeta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science, 1996, 272 (5270):1955−1958.
- Alliegro MB, Cozzilpri A, Sinicco A, Pezzotti P, Rezza G. Effect of coinfection with HIV and HBV in the progression to AIDS and death. In: Abstracts of the 12th World AIDS Conference, Geneva, Switzerland, 1998 (Abstract 12 108).
- Allory Y, Charlotte F, Benhamou Y, Opolon P, Le Charpentier Y, Poynard T. Impact of human immunodeficiency virus infection on the histological features of chronic hepatitis C: a case-control study. The MULTIVIRC group. Hum Pathol. 2000, 31 (1): 69−74.
- Amoroso, P, M. Rapicetta, M.E.Tosti. Correlation between virus genotype and chronicity rate in acute hepatitis C. J Hepatol. 1998, 28: 939−944.
- Apetrei C, Necula A, Holm-Hansen C, Loussert-Ajaka I, Pandrea I, Cozmei C, Streinu-Cercel A, Pascu FR, Negut E, Molnar G, Duca M, Pecec M, Brun-Vezinet F, Simon F. HIV-1 diversity in Romania. AIDS, 1998, 12(9): 1079−1085.
- Autran В, Carcelain G, Li TS, Blanc C, Mathez D, Tubiana R, Katlama C, Debre P, Leibowitch J. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science, 1997, 277: 112−116.
- Bangham CRM. HTLV-I infections. J Clin Pathol. 2000, 53: 581−586.
- Bantel H, Lugering A, Poremba C, Lugering N, Held J, Domschke W, Schulze-Osthoff K. Caspase activation correlates with the degree of inflammatory liver injury in chronic hepatitis С virus infection. Hepatology, 2001, 34 (4 Pt 1): 758−767.
- Beasley, R. Hepatitis В virus: the major etiology of hepatocellular carcinoma. Cancer, 1988, 61:1942−1956.
- Behrens SE, Tomei L, De Francesco R. Identification and properties of the RNA-dependent RNA polymerase of hepatitis С virus. EMBOJ. 1996,15 (1): 12−22.
- Beld M, Penning M, Lukashov V, McMorrow M, Roos M, Pakker N, van den Hoek A, Goudsmit J. Evidence that both HIV and HIV-induced immunodeficiency enhance HCV replication among HCV seroconverters. Virology, 1998,244 (2): 504−512.
- Benkirane M, Jin DY, Chun RF, Koup RA, Jeang KT. Mechanism of transdominant inhibition of CCR5-mediated HIV-l infection by ccr5delta32. J Biol Chem. 1997, 272 (49): 30 603−30 606.
- Bessesen M, Ives D, Condreay L, Lawrence S, Sherman KE. Chronic active hepatitis В exacerbations in human immunodeficiency virus-infected patients following development of resistance to or withdrawal of lamivudine. Clin Infect Dis. 1999, 28: 1032−1035.
- Beyrer С, Razak MH, Lisam К, Chen J, Lui W, Yu XF. Overland heroin trafficking routes and HIV-1 spread in south and south-east Asia. AIDS, 2000,14 (1): 75−83.
- Bobkov A, Cheingsong-Popov R, Selimova L, Ladnaya N, Kazennova E, Kravchenko A, Pokrovsky V, Weber J. HIV type 1 subtype E in Russia. AIDS Res Hum Retroviruses, 1997a, 13: 725−727.
- Bobkova MR, Detkova NV, Buravtsova EV, Bondarenko VO, Bobkov AF, Pokrovsky VV, Taylor GP. Low prevalence of HTLV-I/II infection among HIV-1-infected injecting drug users in Russia. J Acquir Immune Deftc Syndr Hum Retrovirol. 1999,21 (4): 354.
- Bodsworth NJ, Cooper DA, Donovan, B. The influence of human immunodeficiency virus type 1 infection on the development of hepatitis В virus carrier state. J Infect Dis. 1991,163:1138−1140.
- Boisvert J, He XS, Cheung R, Keeffe EB, Wright T, Greenberg HB. Quantitative analysis of hepatitis с virus in peripheral blood and liver: replication detected only in liver. J Infect Dis. 2001, 184 (7): 827−835.
- Bowden S. New hepatitis viruses: contenders and pretenders. J Gastroenterol Hepatol. 2001, 16(2): 124−131.
- Brinkman K, ter Hofstede HJ, Burger DM, Smeitink JA, Koopmans PP. Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway. AIDS, 1998,12:1735−1744.
- Brites C, Alencar R, Gusmao R, Pedroso C, Netto EM, Pedral-Sampaio D, Badaro R.Co-infection with HTLV-1 is associated with a shorter survival time for HIV-1-infected patients in Bahia, Brazil. AIDS, 2001, 15 (15): 2053−2055.
- Bronowicki JP, Venard V, Botte C, Monhoven N, Gastin I, Chone L, Hudziak H, Rhin B, Delanoe C, LeFaou A, Bigard MA, Gaucher P. Patient-to-patient transmission of hepatitis С virus during colonoscopy. N Engl J Med. 1997, 337: 237−240.
- Bruno R, Sacchi P, Malfitano A, Filice G. YMDD-mutant HBV strain as a cause of liver failure in an HIV-infected patient. Gastroenterology, 2001, 121 (4): 1027−1028.
- Busch MP, Laycock M, Kleinman SH, Wages JW Jr, Calabro M, Kaplan JE, Khabbaz RF, Hollingsworth CG. Accuracy of supplementary serologic testing for human T-lymphotrophic virus types I and II in U.S. blood donors. Blood, 1994, 83:1143−1148.
- Butler T, Spencer J, Cui J, Vickery K, Zou J, Kaldor J. Seroprevalence of markers for hepatitis В, С and G in male and female prisoners—NSW, 1996. Aust N Z J Public Health, 1999,23 (4): 377−384.
- Cabot B, Martell M, Esteban JI, Sauleda S, Otero T, Esteban R, Guardia J, Gomez J. Nucleotide and amino acid complexity of hepatitis С virus quasispecies in serum and liver. J Virol. 2000, 74 (2): 805−811.
- Cann AJ, Chen ISY. Human T-cell leukemia virus types I and II. In: Fields BN, Knipe DM, Howley PM et al, eds. Fields virology, Vol. 59, Philadelphia: Raven Publishers, 1996: 1849−1880.
- Cao YZ, Dieterich D, Thomas PA, Huang YX, Mirabile M, Ho DD. Identification and quantitation of HIV-1 in the liver of patients with AIDS. AIDS, 1992, 6 (1): 65−70.
- Carrington M, Nelson GW, Martin MP, Kissner T, Vlahov D, Goedert JJ, Kaslow R, Buchbinder S, Hoots K, O’Brien SJ. HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science, 1999, 283 (5408): 1748−1752.
- Caussin-Schwemling C, Schmitt C, Stoll-Keller F. Study of the infection of human blood derived monocyte/macrophages with hepatitis С virus in vitro. J Med Virol. 2001, 65 (l):14−22.
- Centers for Disease Control and Prevention, the USPHS Working Group: Guidelines for counseling persons infected with human T-lymphotrophic virus type I (HTLV-I) and type II (HTLV-II). Ann Intern Med. 1993, 118:448−454.
- Cha ТА, Beall E, Irvine B, Kolberg J, Chien D, Kuo G, Urdea MS. At least five related, but distinct, hepatitis С viral genotypes exist. Proc Natl Acad Sci USA, 1992, 89: 71 447 148.
- Chamberlain RW, Adams N, Saeed AA, Simmonds P, Elliott RM. Complete nucleotide sequence of a type 4 hepatitis С virus variant, the predominant genotype in the Middle East. J Gen Virol. 1997,78: 1341−1347.
- Cheingsong-Popov R, Chappey C, Callow D, Lister S, Bobkov A, Weber J. HIV-1 V3 serotypes: distribution and correlation with genotypes. In: X International Conference on AIDS. Yokohama, Japan, August 7−12,1994a (Abstact PC0430).
- Chen CH, Vazquez-Padua M, Cheng YC. Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity. Mol Pharmacol. 1991, 39 (5): 625−628.
- Chen JD, Bai X, Yang AG, Cong Y, Chen SY. Inactivation of HIV-1 chemokine co-receptor CXCR-4 by a novel intrakine strategy. Nat Med. 1997, 3 (10): 1110−1116.
- Chen LB, Chen PL, Tian HY, Liu CH, Li L, An PI. Identification and visualization of virus-like particles in peripheral blood mononuclear cells. Zhongh.ua Shi Yon He Lin Chuang Bing DuXue Za Zhi. 2000,14 (1): 14−18.
- Chen YM, Essex M. Identification of a recombinant HTLV-II envelope protein for serological detection of HTLV-II carriers. AIDS Res. Hum. Retroviruses, 1991, 7: 453 457.
- Chomezynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinum thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987, 162:156−159.
- Cohen S.N., Chang A. Hsu L. Nonchromosomal antibiotic resistace in bacteria: genetic transformation of Escherichia coli by R-factor DNA. Proc Natl Acad Sci USA. 1972, 69 (8): 2110−2114.
- Collier AC, Corey L, Murphy VL, Handsfield HH. Antibody to human immunodeficiency virus (HIV) and a suboptimal response to hepatitis В vaccination. Ann Intern Med. 1988, 109:101−105.
- Colombatto P, Baldi M, Oliveri F, Randone A, Bonino F, Brunetto MR. Tailoring interferon dose and monitoring viral load in hepatitis С virus genotype lb infected patients: a pilot study. Dig Liver Dis. 2000, 32 (3): 211−216.
- Corey L. HSY-HIV interactions: under-appreciated by all except the pathogens themselves. In: Program and abstracts of the 39th Annual Meeting of the Infectious Diseases Society of America- October 25−28, 2001- San Francisco, California. Abstract P88.
- Cortes E, Detels R, Aboulafia D, Li XL, Moudgil T, Alam M, Bonecker C, Gonzaga A, Oyafuso L, Tondo M. HIV-1, HIV-2, and HTLV-I infection in high risk groups in Brazil. NEngl J Med. 1989,320: 953−958.
- Crofts N, Hopper JL, Milner R, Breschkin AM, Bowden DS, Locarnini SA. Blood-borne virus infections among Australian injecting drug users: implications for spread of HIV. Eur J Epidemiol. 1994,10 (6): 687−694.
- Delwart E, Shpaer EG, Louwagie J, McCutchan F, Grez M, Ruebsamen-Waigmann H, and JI Mullins: Genetic relationships determined by a DNA heteroduplex mobility assay analysis of HIV-1 env genes. Science, 1993,262:1257−1261.
- Dietrich DT. HIV and viral hepatitis. The PRNNotebook, 1999,4 (3): 5−10.
- Dimitrakopoulos А, Такой A, Haida A, Molangeli S, Gialeraki A, Kordossis T. The prevalence of hepatitis В and С in HIV-positive Greek patients: relationship to survival of deceased AIDS patients. J Infect. 2000, 40 (2):127−131.
- Dubuisson J, Hsu HH, Cheung RC, Greenberg HB, Russell DG, Rice CM. Formation and intracellular localization of hepatitis С virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses. J Virol. 1994, 68 (10):6147−6160.
- Dusheiko G, Schmilovitz-Weiss H, Brown D, McOmish F, Yap PL, Sherlock S, Mclntyre N, Simmonds P. Hepatitis С virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology, 1994,19:13−18.
- Edlich RF, Arnette JA, Williams FM. Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I). J Emerg Med 2000 Jan-18(l):109−19.
- Eyster ME, Fried MW, Di Bisceglie AM, Goedert JJ. Increasing hepatitis С virus RNA levels in hemophiliacs: relationship to human immunodeficiency virus infection and liver disease. Multicenter Hemophilia Cohort Study. Blood, 1994, 84 (4): 1020−1023.
- Eyster ME, Sherman KE, Goedert JJ, Katsoulidou A, Hatzakis A. Prevalence and changes in hepatitis С virus genotypes among multitransfused persons with hemophilia. J Infect Dis. 1999,179:1062−1069.
- Failla C, Tomei L, De Francesco R. Both NS3 and NS4A are required for proteolytic processing of hepatitis С virus nonstructural proteins. J Virol. 1994, 68 (6): 3753−3760.
- Farci P, Shimoda A, Coiana A, Diaz G, Peddis G, Melpolder JC, Strazzera A, Chien DY, Munoz SJ, Balestrieri A, Purcell RH, Alter HJ. The outcome of hepatitis С is predicted by the evolution of viral quasispecies. Science, 2000,288: 339−344.
- Felsenstein J. PHYLIP-phylogenetic interference package (version 3.2). Cladistics, 1989, 5:164−166.
- Ferbeyre G, Bourdeau V, Cededergren R. Does HIV tat protein also regulate genes of other viruses present in HIV infection? Trends Biochem Sci. 1997,22: 155−156.
- Ferdats A, Konicheva V, Dievberna I, Lilja E, Albert J. An HIV type 1 subtype A outbreak among injecting drug users in Latvia AIDS Res Hum Retroviruses, 1999, 15 (16): 1487−1490.
- Forns X, Bukh J. The molecular biology of hepatitis С virus. Genotypes and quasispecies. Clin Liver Dis. 1999, 3 (4):693−716, vii.
- Franchini G. Molecular mechanisms of human T-cell leukaemia/lymphotropic virus type I infection. Blood, 1995, 86: 3619−3639.
- Galeazzi B, Tufano A, Barbierato E, Bortolptti F. Hepatitis С virus infection in Italian intravenous drug users: epidemiological and clinical aspects. Liver, 1995,15 (4): 209−212.
- Garcia F, Roldan C, Hernandez-Quero J, Bernal MC, Martinez MA, Lopez MA, Piedrola G, Maroto MC. Relationship between viral genotype and viral load in patients with chronic hepatitis C. Eur J Clin Microbiol Infect Dis. 1996, 15 (11): 884−887.
- Garcia-Samaniego J, Rodriguez M, Berenguer J, Rodriguez-Rosado R, Carbo J, Asensi V, Soriano V. Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C. Am J Gastroenterol 2001, 96 (1): 179−183.
- Gavazzi G, Richallet G, Morand P, Bouchard O, Bosseray A, Leclercq P, Micoud M. Effects of double and triple antiretroviral agents on the HCV viral load in patients coinfected with HIV and HCV. Pathol Biol. 1998, 46:412−415.
- Gelmann EP, Franchini G, Manzari V, Wong-Staal F, Gallo RC. Molecular cloning of a unique human T-cell leukemia virus (HTLV-IIMo). Proc Natl Acad Sci USA, 1984, 81 (4): 993−997.
- Goedert JJ, Fung MW, Felton S, Battjes RJ, Engels EA. Cause-specific mortality associated with HIV and HTLV-II infections among injecting drug users in the USA. AIDS, 2001,15 (10):1295−1302.
- Gordon FD, Poterucha JJ, Germer J, Zein NN, Batts KP, Gross JB Jr, Wiesner R, Persing D. Relationship between hepatitis С genotype and severity of recurrent hepatitis С after liver transplantation. Transplantation, 1997,63 (10): 1419−1423.
- Gruener NH, Lechner F, Jung MC, Diepolder H, Gerlach T, Lauer G, Walker B, Sullivan J, Phillips R, Pape GR, Klenerman P. Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis С virus. J Virol 2001, 75 (12): 5550−5558.
- Guenthner PC, Hershow RC, Lai RB, Dezzutti CS. Effects of human T-lymphotropic virus type II on human immunodeficiency virus type 1 phenotypic evolution. Arch Virol. 2001,146 (8): 1617−1622.
- Gunn RA, Murray PJ, Ackers ML, Hardison WG, Margolis HS. Screening for chronic hepatitis В and С virus infections in an urban sexually transmitted disease clinic: rationale for integrating services. Sex Transm Dis, 2001,28 (3): 166−170.
- Gurtsevitch V, Senyuta N, Shih J, Stepina V, Pavlish O, Syrtsev A, Susova O, Yakovleva L, Scherbak L, Hayami M. HTLV-I infection among Nivkhi people in Sakhalin. Int J Cancer, 1995,60:432−433.
- Hadlock KG, Lipka JJ, Chow TP, Foung SK, Reyes GR. Cloning and analysis of a recombinant antigen containing an epitope specific for human T-cell lymphotropic virus type II. Blood, 1992, 79 (10): 2789−2796.
- Hagan H, Des Jarlais DC. HIV and HCV infection among injecting drug users. Mt Sinai J Med. 2000,67 (5−6): 423−428.
- Harris KA, Gilham C, Mortimer PP, Teo CG. The most prevalent hepatitis С virus genotypes in England and Wales are 3a and la. J Med Virol. 1999, 58 (2): 127−131.
- Haushofer AC, Kopty C, Hauer R, Brunner H, Halbmayer WM. HCV genotypes and age distribution in patients of Vienna and surrounding areas. J Clin Virol 2001,20 (1−2): 41−47.
- Hayashi N, Mita E. Involvement of Fas system-mediated apoptosis in pathogenesis of viral hepatitis. J Viral Hepat. 1999, 6 (5): 357−365.
- Higgins DG, Bleasby AJ, Fuchs R. CLUSTAL V: Improved software for multiple sequence alignment. Comput Appl Biosci. 1992,8:189−191.
- Hisada M, O’Brien TR, Rosenberg PS, Goedert JJ. Virus load and risk of heterosexual transmission of human immunodeficiency virus and hepatitis С virus by men with hemophilia. J Infect Dis. 2000,181 (4): 1475−1478.
- Hohne M, Schreier E, Roggendorf M. Sequence variability in the env-coding region of hepatitis С virus isolated from patients infected during a single source outbreak. Arch Virol. 1994,137:25−34.
- Hollsberg P, Hafler DA: Pathogenesis of diseases induced by human lymphotrophic virus type I infection. N Engl J Med. 1993,328:1173−1182.
- Hoofhagle JH, Mullen KD, Jones DB, Rustgi V, Di Bisceglie A, Peters M, Waggoner JG, Park Y, Jones EA. Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon. A preliminary report. NEngl J Med. 1986,315 (25): 1575−1578.
- Housset C, Lamas E, Courgnaud V, Boucher O, Girard PM, Marche C, Brechot C. Presence of HIV-1 in human parenchymal and non-parenchymal liver cells in vivo. J Hepatol 1993, 19 (2):252−258.
- Hufert FT, Schmitz J, Schreiber M, Schmitz H, Racz P, von Laer DD. Human Kupffer cells infected with HIV-1 in vivo. JAcquir Immune Defic Syndr. 1993, 6 (7): 772−777.
- Ijichi S, Ramundo MB, Takahashi H, Hall WW. In vivo cellular tropism of human T-lymphotropic virus type II (HTLV-II). J Exp Med. 1992,176: 293−296.
- Jiang W, Gu S, Hu Y. Genotyping of HCV isolates from different populations in Shanghai by using second generation line probe assay. Zhonghua Gan Zang Bing Za Zhi, 1999, 7(1): 29−30 [Article in Chinese].
- John M, Flexman J, French MA. Hepatitis С virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors: an immune restoration disease? AIDS, 1998,12: 2289−2293.
- Justice AC, Chang CH, Fusco J, West N. Extrapolating long-term HIV/AIDS survival in the post-HAART era. In: Abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy- September 26−29, 1999- San Francisco. Abstract 1158.
- Kakuda TN, Brundage RC, Anderson PL, Fletcher CV. Nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity as an etiology for lipodystrophy. AIDS, 1999, 13 (16): 2311−2312.
- Kalyanaraman VS, Sarngadharan MG, Robert-Guroff M, Miyoshi I, Golde D, Gallo RC. A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science, 1982,218: 571−573.
- Kato N, Ootsuyama Y, Ohkoshi S, Nakazawa T, Sekiya H, Hijikata M, Shimotohno K. Characterization of hypervariable regions in the putative envelope protein of hepatitis С virus. Biochem Biophys Res Commun. 1992, 189: 119−127.
- Kato N, Ootsuyama Y, Tanaka T, Nakagawa M, Nakazawa T, Muraiso K, Ohkoshi S, Hijikata M, Shimotohno K. Marked sequence diversity in the putative envelope proteins of hepatitis С viruses. Virus Res. 1992,22 (2): 107−23.
- Kato N. Molecular virology of hepatitis С virus. Acta Med. Okayama, 2001, 55 (3): 133−159.
- Kekule AS, Lauer U, Weiss L, Luber B, Hofschneider PH. Hepatitis В virus transaetivator HBx uses a tumour promoter signalling pathway. Nature, 1993, 361 (6414): 742−745.
- Khabbaz RF, Onorato IM, Cannon RO, Hartley TM, Roberts B, Hosein B, Kaplan JE. Seroprevalence of HTLV-I and HTLV-II among intravenous drug users and persons in clinics for sexually transmitted diseases. N Engl J Med. 1992, 326: 375−380.
- Kim DW, Gwack Y, Han JH, Choe J. C-terminal domain of the hepatitis С virus NS3 protein contains an RNA helicase activity. Biochem Biophys Res Commun. 1995, 215 (1):160−166.
- Kimura M. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequence. J Mol Evol. 1980,16: 111−120.
- Kirchhoff F, Greenough TC, Brettler DB, Sullivan JL, Desrosiers RC. Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N Engl J Med. 1995, 332 (4): 228−232.
- Kita H, Hiroishi K, Moriyama T, Okamoto H, Kaneko T, Ohnishi S, Yazaki Y, Imawari M. A minimal and optimal cytotoxic T cell epitope within hepatitis С virus nucleoprotein. Gen Virol. 1995,76 (Pt 12): 3189−3193.
- Lairmore MD, Jason JM, Hartley TM, Khabbaz RF, De B, Evatt BL. Absence of human T-cell lymphotrophic virus type I coinfection in human immunodeficiency virus infected hemophilic men. Blood, 1989,74: 2596−2599.
- Langman P, Klinker H, Weisbrich В et al. In: Abstracts of the 6th European Conference on Clinical Aspects and Treatment of HIV-infection. Hamburg, Germany, 1997 (Abstract 816).
- Large MK, Kittlesen DJ, Hahn YS. Suppression of host immune response by the core protein of hepatitis С virus: possible implications for hepatitis С virus persistence. J Immunol. 1999, 162 (2): 931−938.
- Laskus T, Radkowski M, Wang LF, Jang SJ, Vargas H, Rakela J. Hepatitis С virus quasispecies in patients infected with HIV-1: correlation with extrahepatic viral replication. Virology, 1998, 248 (1): 164−171.
- Leitner T, Korovina G, Marquina S, Smolskaya T, Albert J. Molecular epidemiology and MT-2 cell tropism of Russian HIV type 1 variant. AIDS Res Hum Retroviruses, 1996, 12 (17): 1595−1603.
- Lewis MJ, Gautier VW, Wang XP, Kaplan MH, Hall WW. Spontaneous production of C-C chemokines by individuals infected with human T lymphotropic virus type II (HTLV-II) alone and HTLV-II/HIV-1 coinfected individuals. J Immunol. 2000, 165 (7): 4127−4132.
- Li X, Jeffers LJ, Garon C, Fischer ER, Scheffel J, Moore B, Reddy KR, Demedina M, Schiff ER. Persistence of hepatitis С virus in a human megakaryoblastic leukaemia cell line. J Viral Hepat. 1999, 6 (2): 107−114.
- Liberman E, Fong YL, Selby MJ, Choo QL, Cousens L, Houghton M, Yen TS. Activation of the grp78 and grp94 promoters by hepatitis С virus E2 envelope protein. J Virol 1999, 73 (5): 3718−3722.
- Licensure of screening tests for antibody to human T-lymphotrophic virus type I. MMWR, 1988,37: 736−740,745.
- Lillo F, Varnier OE, Sabbatani S, Ferro A, Mendez P. Detection of HTLV-I and not HTLV-II infection in Guinea Bissau (West Africa). J Acquir Immune Defic Syndr. (lett), 1991, 4: 541−542.
- Louwagie J, Delwart EL, Mullins JI, McCutchan FE, Eddy G, Burke DS. Genetic analysis of HIV-1 isolates from Brazil reveals presence of two distinct genetic subtypes. AIDS Res Hum Retroviruses, 1994, 10 (5): 561−567.
- Lukashov VV, Karamov EV, Eremin VF, Titov LP, Goudsmit J. Extreme founder effect in an HIV type 1 subtype A epidemic among drug users in Svetlogorsk, Belarus. AIDS Res Hum Retroviruses, 1998,14(14): 1299−1303.
- Mangano А, Корка J, Batalla M, Bologna R, Sen L. Protective effect of CCR2−64I and not of CCR5-delta32 and SDFl-З'А in pediatric HIV-l infection. J Acquir Immune Defic Syndr. 2000,23 (1): 52−57.
- Mao Q, Ray SC, Laeyendecker O, Ticehurst JR, Strathdee SA, Vlahov D, Thomas DL. Human immunodeficiency virus seroconversion and evolution of the hepatitis С virus quasispecies. J Virol. 2001, 75 (7): 3259−3267.
- Martin P, Di Bisceglie AM, Kassianides C, Lisker-Melman M, Hoofriagle JH. Rapidly progressive non-A, non-B hepatitis in patients with human immunodeficiency virus infection. Gastroenterology, 1989, 97(6): 1559−1561.
- Martinson JJ, Hong L, Karanicolas R, Moore JP, Kostrikis LG. Global distribution of the CCR2−64I/CCR5−59653T HIV-1 disease-protective haplotype. AIDS, 2000,14 (5): 483−489.
- Marusawa H, Hijikata M, Chiba T, Shimotohno K. Hepatitis С virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-kappaB activation. J Virol. 1999, 73 (6): 4713−4720.
- Mas A, Espanol T, Heredia A, Pedraza MA, Hernandez M, Caragol I, Fernando M, Bertran JM, Alcami J, Soriano V. CCR5 genotype and HIV-1 infection in perinatally-exposed infants. J Infect. 1999,38 (1): 9−11.
- Matthews-Greer JM, Caldito GC, Adley SD, Willis R, Mire AC, Jamison RM, McRae KL, King JW, Chang W.-L. Comparison of Hepatitis С Viral Loads in Patients with or without Human Immunodeficiency Virus. Clin Diagn Lab Immunol. 2001, 8 (4): 690−694.
- Mehal WZ, Azzaroli F, Crispe IN. Antigen presentation by liver cells controls intrahepatic T cell trapping, whereas bone marrow-derived cells preferentially promote intrahepatic T cell apoptosis. J Immunol. 2001,167 (2): 667−673.
- Mellado M, Rodriguez-Frade JM, Vila-Coro AJ, de Ana AM, Martinez-A C. Chemokine control of HIV-1 infection. Nature, 1999,400 (6746): 723−724.
- Moore GR, Traugott U, Scheinberg LC, Raine CS. Tropical spastic paraparesis: A model of virus induced, cytotoxic T-cell mediated demyelination? Ann Neurol. 1989, 26:523−530.
- Muller HM, Pfaff E, Goeser T, Kallinowski B, Solbach C, Theilmann L. Peripheral blood leukocytes serve as a possible extrahepatic site for hepatitis С virus replication. J Gen Virol. 1993, 74 (Pt 4): 669−676.
- Murphy EL, Figueroa JP, Gibbs WN, Holding-Cobham M, Cranston B, Malley K, Bodner AJ, Alexander SS, Blattner WA. Human T-lymphotrophic virus type I (HTLV-I)seroprevalence in Jamaica: I. Demographic determinants. Am J Epidemiol 1991, 133: 1114−1124.
- Myers G, Korber B, Berzofsky JA, Smith RF. Human retroviruses and AIDS 1991. Los Alamos: Los Alamos National Laboratory, 1991.
- Nakao T, Enomoto N, Takada N, Takada A, Date T. Typing of hepatitis С virus genomes by restriction fragment length polymorphism. J Gen Virol. 1991, 72 (Pt 9): 2105−2112.
- Neau D, Schvoerer E, Robert D, Dubois F, Dutronc H, Fleury HJ, Ragnaud JM. Hepatitis В exacerbation with a precore mutant virus following withdrawal of lamivudine in a human immunodeficiency virus-infected patient. J Infect Dis. 2000, 41: 192−194.
- Nishioka K, Nakajima T, Hasunuma T, Sato K. Rheumatic manifestations of human leukemic virus infection. Rheum Dis Clin North Am. 1993, 19: 489−503.
- Novitsky VA, Montano MA, Essex M. Molecular epidemiology of an HIV-1 subtype A subcluster among injection drug users in the Southern Ukraine. AIDS Res Hum Retroviruses, 1998,14(12): 1079−1085.
- O’Brien TR, Winkler C, Dean M, Nelson JA, Carrington M, Michael NL, White GC 2nd. HIV-1 infection in a man homozygous for CCR5 delta 32. Lancet, 1997, 349 (9060):1219.
- Osame M, Matsumoto M, Usuku К, Izumo S, Ijichi N, Amitani H, Тага M, Igata A. Chronic progressive myelopathy associated with elevated antibodies in human T-lymphotrophic virus type I and adult T-cell leukemia-like cells. Ann Neurol. 1987, 21: 117−122.
- Ou CY, Takebe Y, Weniger BG, Luo CC, Kalish ML, Auwanit W, Yamazaki S, Gayle HD, Young NL, Schochetman G. Independent introduction of two major HIV-1 genotypes into distinct high-risk populations in Thailand. Lancet, 1993, 341 (8854): 11 711 174.
- Pallas JR, Farinas-Alvarez C, Prieto D, Delgado-Rodriguez M. Coinfections by HIV, hepatitis В and hepatitis С in imprisoned injecting drug users. Eur J Epidemiol, 1999,15 (8): 699−704.
- Parkin, D. M., Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer, 1999, 80: 827−841.
- Pawlotsky JM, Taskiris L, Roudot-Thoraval F, Pellet C, Stuyver, Duval J, Dhumeaux D. Relationship between hepatitis С virus genotypes and sources of infection in patients with chronic hepatitis C. J Infect Dis. 1995,171:1607−1610.
- Penning M, Beld M, Goudsmit J. Peripheral blood mononuclear cells of HIV- and HCV-antibody-positive individuals contain HCV RNA but no HCV DNA despite evidence for reverse transcription of HIV RNA into DNA. Virology, 2000, 268 (1):12−16.
- Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type С retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma Proc Natl Acad Sci USA, 1980, 77: 7415−7419.
- Poles MA, Dietrich DT. Hepatitis С virus/Human immunodeficiency virus coinfection: clinical management issues. Clin Infect Dis. 2000, 31: 154−161.
- Pont J, Neuwald C, Salzner G. Antibody prevalence of parenterally transmitted viruses (HIV-1, HTLV-I, HBV, HCV) in Austrian intravenous drug users. Infection, 1991, 19 (6): 427−430.
- Power JP, Lawlor E, Davidson F, Holmes EC, Yap PL, Simmonds P. Molecular epidemiology of an outbreak of infection with hepatitis С virus in recipients of anti-D immunoglobulin. Lancet, 1995, 345:1211−1213.
- Preugschat F, Averett DR, Clarke BE, Porter DJ. A steady-state and pre-steady-state kinetic analysis of the NTPase activity associated with the hepatitis С virus NS3 helicase domain. J Biol Chem. 1996,271 (40): 24 449−24 457.
- Prilipov A, Phale PS, Van Gelder P, Rosenbusch JP, Koebnik R. Coupling site-directed mutagenesis with high-level expression: large scale production of mutant porins from E.coli. FEMS Microbiol Lett. 1998,163 (1): 65−72.
- Quan CM, Krajden M, Grigoriew GA, Salit IE. Hepatitis С virus infection in patients infected with the human immunodeficiency virus. Clin Infect Dis. 1993, 17(1): 117−119.
- Ragni MV, Belle SH. Impact of human immunodeficiency virus infection on progression to end-stage liver disease in individuals with hemophilia and hepatitis С virus infection. J Infect Dis. 2001,183 (7): 1112−1115.
- Reiser M, Marousis CG, Nelson DR, Lauer G, Gonzalez-Peralta RP, Davis GL, Lau JY. Serum interleukin 4 and interleukin 10 levels in patients with chronic hepatitis С virus infection. J Hepatol. 1993,26: 1103−1113.
- Rosen CA, Pavlakis GN. Tat and Rev: positive regulators of HIV gene expression. AIDS, 1990,4 (6):499−509.
- Rosen HR, Hinrichs DJ, Gretch DR, Koziel MJ, Chou S, Houghton M, Rabkin J, Corless CL, Bouwer HG. Association of multispecific CD4+ response to hepatitis С and severity of recurrence after liver transplantation. Gastroenterology, 1999, 117:926−932.
- Ross RS, Viazov S, Renzing-Kohler K, Roggendorf M. Changes in the epidemiology of hepatitis С infection in Germany: shift in the predominance of hepatitis С subtypes. J Med Virol. 2000,60 (2): 122−125.
- Ruchusatsawat N, Vongsheree S, Thaisri H, Phutiprawan T. The first report of CCR5 delta 32 mutant in Thai injecting drug users. Asian Рас J Allergy Immunol. 2000, 18 (2): 93−98.
- Rutschmann ОТ, Negro F, Hirschel B, Hadengue A, Anwar D, Perrin LH. Impact of treatment with human immunodeficiency virus (HIV) protease inhibitors on hepatitis С viremia in patients co-infected with HIV. J Infect Dis. 1998, 177: 783−785.
- Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, Farber CM, Saragosti S, Lapoumeroulie C, Cognaux J, Forceille C, Muyldermans G, Verhofstede C, Burtonboy G, Georges M, Imai T, Rana S, Yi Y, Smyth RJ, Collman RG, Doms RW, Vassart G,
- Parmentier M. Resistance to HIV-l infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature, 1996, 382 (6593): 722−725.
- Sankov M, Bobkova M, Bobkov A. HTLV-I/II and HCV prevalence in dermal patients in Moscow, Russia. In: Abstracts of the 8th European Congress of clinical microbiology and infectious diseases, Lausanne, Switzerland, May 25−28, 1997, P0982.
- Sankov MN, Bobkova MR, Khanina ТА, Bobkov AF, Zverev SY, Terskikh VA. Study of HTLV-1 prevalence in patients with sexually transmitted diseases in Perm' and Ekaterinburg, Russia. J Acquir Immune Defic Syndr Hum Retrovirol. 1998, 17 (1): 9798.
- Schinazi RF, Larder В A, Mellors JW: Mutations in retroviral genes associated with drug resistance. Int Antiviral News, 1997, 5: 129−142.
- Sheremata WA, Harrington WJ Jr, Bradshaw PA, Foung SK, Raffanti SP, Berger JR, Snodgrass S, Resnick L, Poiesz BJ. Association of «tropical ataxic neuropathy» with HTLV-II. Virus Res. 1993,29: 71−77.
- Sherman KE, Andreatta C, O’Brien J, Gutierrez A, Harris R. Hepatitis С in human immunodeficiency virus-coinfected patients: increased variability in the hypervariable envelope coding domain. Hepatology, 1996, 23 (4): 688−694.
- Sherman KE, Freeman S, Harrison S, Andron L. Prevalence of antibody to hepatitis С virus in patients infected with the human immunodeficiency virus. J Infect Dis. 1991, 163(2): 414−415.
- Sherman KE, O’Brien J, Gutierrez AG, Harrison S, Urdea M, Neuwald P, Wilber J. Quantitative evaluation of hepatitis С virus RNA in patients with concurrent human immunodeficiency virus infections. J Clin Microbiol. 1993, 31 (10): 2679−2682.
- Shibata M, Wang RY, Yoshiba M, Shih JW, Alter HJ, Mitamura K. The presence of a newly identified infectious agent (SEN virus) in patients with liver diseases and in blood donors in Japan. J Infect ?>«.2001, 184 (4): 400−404.
- Shibayama T, Masuda G, Ajisawa A, Takahashi M, Nishizawa T, Tsuda F, Okamoto H. Inverse relationship between the titre of TT virus DNA and the CD4 cell count in patients infected with HIV. AIDS, 2001, 15 (5): 563−570.
- Shih J, Senjuta N, Stepina V et al. HTLV seroprevalence in regions of the former USSR. In: Proceedings IXInternational Conference on AIDS, Berlin, June 1993: 683.
- Shimamoto Y, Suga K, Shibata K, Matsuzaki M, Yano H, Yamaguchi M. Clinical importance of extraordinary integration pattern of human T-cell lymphotrophic virus type I proviral DNA in adult T-cell leukemia/lymphoma. Blood, 1994, 84: 853−858.
- Shobokshi OA, Serebour FE, Skakni L, Al-Saffy YH, Ahdal MN. Hepatitis С genotypes and subtypes in Saudi Arabia. J Med Virol, 1999, 58 (1): 44−48.
- Shrestha SM, Shrestha DM, Gafiiey ТЕ, Maharjan KG, Tsuda F, Okamoto H. Hepatitis В and С infection among drug abusers in Nepal. Trop Gastroenterol. 1996, 17 (4): 212−213.
- Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, Brechot C, Brouwer JT, Chan SW, Chayama K, Chen DS, et al. A proposed system for the nomenclature of hepatitis С viral genotypes. Hepatology, 1994, 19 (5):1321−1324.
- Simmons G, Clapham PR, Picard L, Offord RE, Rosenkilde MM, Schwartz TW, Buser R, Wells TN, Proudfoot AE. Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. Science, 1997,276 (5310): 276−279.
- Sisk WP, Bradley JD, Kingsley D, Patterson ТА. Deletion of hydrophobic domains of viral glycoproteins increases the level of their production in Escherichia coli. Gene, 1992, 112:157−162.
- Smyth BP, Keenan E, O’Connor JJ. Bloodborne viral infection in Irish injecting drug users. Addiction, 1998,93 (11): 1649−1656.
- Somaini В, Wang J, Perozo M, Kuhn F, Meili D, Grob P, Flepp M. A continuing concern: HIV and hepatitis testing and prevalence among drug users in substitution programmes in Zurich, Switzerland. AIDS Care, 2000, 12 (4):449−460.
- Sommerfelt MA, Williams BP, Clapham PR, Solomon E, Goodfellow PN, Weiss RA. Human T-cell leukemia viruses use a receptor determined by human chromosome 17. Science, 1988,242:1557−1559.
- Soriano V, Garcia-Samaniego J, Valencia E, Rodriguez-Rosado R, Munoz F, Gonzalez-Lahoz J. Impact of chronic liver disease due to hepatitis viruses as a cause of hospital admission and death in HIV-infected drug users. Eur J Epidemiol. 1999, 15: 1−4.
- Stevens, CE, Toy PT, Tong MJ, Taylor PE, Vyas GN, Nair PV, Gudavalli M, Krugman S. Perinatal hepatitis В virus transmission in the United States: prevention by passive-active immunization. JAMA, 1985, 253: 1740−1745.
- Subbramanian RA, Cohen EA. Molecular biology of the human immunodeficiency virus accessory proteins. J Virol. 1994, 68 (11): 6831−6835.
- Sugiyama H, Doi H, Yamaguchi K, Tsuji Y, Miyamoto T, Hino S. Significance of post-natal mother to child transmission of human T- lymphotrophic virus type I on the development of adult T-cell leukemia/lymphoma. J Med Virol. 1986,20:253−260.
- Sulkowski MS, Thomas DL, Chaisson RE, Moore RD. Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis С or В virus infection. JAMA, 2000,283: 74−80.
- Tajima KT and B-Cell Malignancy Study Group, et al: The 4th nation-wide study of adult T-cell leukemia/lymphoma (ATL) in Japan: Estimates of risk of ATL and its geographical and clinical features. Int J Cancer, 1990,45:237−243.
- Tajiri H, Miyoshi Y, Funada S, Etani Y, Abe J, Onodera T, Goto M, Funato M, Ida S, Noda C, Nakayama M, Okada S. Prospective study of mother-to-infant transmission of hepatitis С virus. Pediatr Infect Dis J. 2001, 20 (1): 10−14.
- Takada N, Takase S, Takada A, Date T. Differences in the hepatitis С virus genotypes in different countries. J Hepatol. 1993, 17:277−283.
- Taylor DR, Shi ST, Romano PR, Barber GN, Lai MM. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science, 2000,287 (5458): 1555.
- The HTLV European Research Network. Seroepidemiology of the human T-cell leukaemia/lymphoma viruses in Europe. J Aquir Immune Defic Syndr Hum Retrovirol. 1996,13: 66−77.
- The HTLV European Research Network, 1994−1997. Imperial College of Science, Technology and Medicine, April 1998.
- Thierbaut R, Morlat P, Jacqmin-Gadda H, Neau D, Mercie P, Dabis F, Chene G. Clinical progression of HIV-1 infection according to the viral response during the first year of antiretroviral treatment. AIDS, 2000- 14 (8): 971−978.
- Thomas DL, Astemborski J, Vlahov D, Strathdee SA, Ray SC, Nelson KE, Galai N, Nolt KR, Laeyendecker O, Todd JA Determinants of the Quantity of Hepatitis С Virus RNA. J Infect Dis. 2000,181 (3): 844−851.
- Thomas DL, Shin JW, Alter HJ, Vlahov D, Cohn S, Hoover DR, Cheung L, Nelson KE. Effect of human immunodeficiency virus on hepatitis С virus infection among injecting drug users. J Infect Dis. 1996, 174: 690−695.
- Thomas DL. Mother-infant hepatitis С transmission: second generation research. Hepatology, 1999,29: 992−993.
- Tian D, Yang D, Wang W, Xia Q, Shi S, Song P, Theilmann L. Extrahepatic and intrahepatic replication and expression of hepatitis С virus. J Tongji Med Univ. 1998, 18 (3): 149−152.
- Tiollais P, Buendia M. Hepatitis В Virus. Scientific American, 1991,264: 48−54.
- Towbin H, Staehelin Т., Gordon J. Electroforetic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some application Proc Natl AcadSci. 1979, 76 (13): 4350−4353.
- Tsai SL, Liaw YF, Chen MH, Huang CY, Kuo GC. Detection of type-2-like T-helper cells in hepatitis С virus infection: implications foe hepatitis С virus chronicity. Hepatology, 1997,35: 449−458.
- Uchiyama T. Human T-cell leukemia virus type I (HTLV-I) and HTLV-I-associated diseases. Annu Rev Immunol. 1997, 15: 15−37.
- Ustina V, Zilmer K, Tammai L, Raukas M, Andersson A, Lilja E, Albert J. Epidemiology of HIV in Estonia. AIDS Res Hum Retroviruses, 2001, 17 (1): 81−85.
- Vaishnav YN, Wong-Staal F. The biochemistry of AIDS. Annu Rev Biochem. 1991,60: 577−630.
- Viazov S, Widell A, Nordenfelt E. Mixed infection with two types of hepatitis С virus is probably a rare event. Infection, 2000,28 (1): 21−25.
- Wang JT, Sheu JC, Lin JT, Wang TH, Chen DS. Detection of replicative form of hepatitis С virus RNA in peripheral blood mononuclear cells. J Infect Dis. 1992, 166 (5): 1167−1169.
- Weiner AJ, Thaler MM, Crawford K, Ching K, Kansopon J, Chien DY, Hall JE, Hu F, Houghton M. A unique, predominant hepatitis С virus variant found in an infant born to a mother with multiple variants. J Virol. 1993, 67: 4365−4368.
- Weiss SH: The evolving epidemiology of human T-lymphotropic virus type II. J Infect Dis. 1994, 169: 1080−1083.
- Westin J, Lindh M, Lagging LM, Norkrans G, Wejstal R. Chronic hepatitis С in Sweden: genotype distribution over time in different epidemiological settings. Scand J Infect Dis, 1999, 31 (4): 355−358.
- Williams AE, Fang CT, Slamon DJ, Poiesz BJ, Sandler SG, Darr WF 2nd, Shulman G, McGowan EI, Douglas DK, Bowman RJ, et al. Seroprevalence and epidemiologic correlates of HTLV-I infection in U.S. blood donors. Science, 1988,240: 643−646.
- Woitas RP, Rockstroh JK, Beier I, Jung G, Kochan B, Matz B, Brackmann HH, Sauerbruch T, Spengler U. Antigen-specific cytokine response to hepatitis С virus core epitopes in HIV/hepatitis С virus-coinfected patients. AIDS, 1999,13:1313−1322.
- Xiang J, Wunschmann S, Diekema DJ, Klinzman D, Patrick KD, George SL, Stapleton JT. Effect of coinfection with GB virus С on survival among patients with HIV infection NEngl J Med. 2001, 345 (10): 707−714.
- Yasui K, Wakita T, Tsukiyama-Kohara K, Funahashi SI, Ichikawa M, Kajita T, Moradpour D, Wands JR, Kohara M. The native form and maturation process of hepatitis С virus core protein. J Virol 1998, 72 (7): 6048−55.
- Yen, T.S.B. Regulation of hepatitis В virus gene expression. Semin Virol. 1993, 4: 3342.
- Yokoi K, Kawai H, Akaike M, Mine H, Saito S. Presence of human T-lymphotropic virus type II-related genes in DNA of peripheral leukocytes from patients with autoimmune thyroid diseases. J Med Virol. 1995,45: 382−398.
- Yoshida EM, Buczkowski AK, Giulivi A, Zou S, Forrester LA. A cross-sectional study of SEN virus in liver transplant recipients. Liver Transpl. 2001, 7(6): 521−525.
- Zein NN, Rakela J, Krawitt EL, Reddy KR, Tominaga T, Persing DH, and the Collaborative Study Group. Hepatitis С virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Ann Intern Med. 1996a, 125: 634−639.
- Zein NN, Rakela J, Poterucha JJ, Steers JL, Weisner RH, Persing DH. Hepatitis С genotypes in liver transplant recipients: distribution and lOyear follow-up. Liver Transplant SWg. 1995a, 1: 354−357.
- Zein NN, Rakela J. Interferon therapy in hepatitis C. Semin Gastrointest Dis. 1995b, 6: 46−53.
- Zein NN. Clinical Significance of Hepatitis С Virus Genotypes. Clinical Microbiology Reviews, 2000, 13 (2): 223−235.
- Zhang L, Huang Y, He T, Cao Y, Ho DD. HIV-1 subtype and second-receptor use. Nature, 1996, 383 (6603): 768.
- Zhang X, Han Y, Lu Z, Zhang D, Cai Y. Detection of hepatitis В virus polymerase variations resistant to lamivudine therapy. Chin Med J (Engl), 2000,113 (5): 455−457.
- Zylberberg H, Chaix ML, Rabian C, Rouzioux C, Aulong B, Brechot C, Viard JP, Pol S. Tri-therapy for human immunodeficiency virus does not modify replication of hepatitis С in coinfected patients. Clin Infect Dis. 1998,26: 1104−1106.